Quick search:
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 BrickBio Spins Out EnCapsid: A Novel Gene Therapy Company that Creates Novel AAVs and Enables More Efficient, CRISPR Cas-9 Delivery
2 Neurophth and AAVnerGene Enter Strategic AAV Capsids Partnership for Next-Generation Ophthalmic Gene Therapy
3 Neurophth and AAVnerGene partner on AAV capsids for next-gen ophthalmic gene therapy
4 Cure Genetics Collaborates with Boehringer Ingelheim to Develop Novel AAV Vectors Enabling the Next-generation Liver-targeted Gene Therapy
5 Cure Genetics, Boehringer to develop AAV vectors for gene therapy
6 CEVEC Inks AAV Manufacturing Deal with Biogen
7 Boehringer Ingelheim, Cure Genetics to develop novel AAV
8 Liver tumor in gene therapy recipient raises concerns about virus widely used in treatment
9 Biodistribution of AAV gene transfer vectors in nonhuman primate
10 Global Roundup: Cevec Licenses AAV Program to Biogen | BioSpace
11 Comprehensive adeno-associated virus critical quality attributes analysis with LC-MS on SelectScience
12 Adverum: 'Scarcity of AAV drove inhouse investment'
13 Collaboration formed to develop AAV-based gene therapies for eye disease
14 Biogen Licenses CEVEC AAV Mfg. Technology
15 Scalable AAV Manufacturing: Addressing Challenges Across the Workflow
16 Aldevron Now Offering AAV Rep/Cap Plasmids for Viral Vector Production
17 ViGeneron, Biogen to develop AAV-based gene therapies for eye disease
18 Rocket Pharmaceuticals to build AAV manufacturing facility in NJ
19 Does Trevor Bauer Have A Case For Gerrit Cole's AAV?
20 Anthony Cirelli re-signed to a 3-year, 4.8M AAV contract
21 How Bauer stacks up against Cole, Stras
22 Gene Therapy Study for Monogenic Blindness Fails to Meet Endpoint
23 AAV In Conversation with Cyril Tetaz of Amadeus on the state of the aviation industry & technology
24 Taysha Gene Therapies and UT Southwestern Medical Center Launch Innovation Fund to Accelerate Advancement of AAV Gene Therapies for Monogenic Diseases of the Central Nervous System
25 Marine Corps Identifies 9 Killed In AAV Accident
26 Neurogene in tie up with university to advance gene therapy technologies
27 EHang to Provide UAM Services in Hengqin New Area in Zhuhai, China
28 Efficacy of plasma exchange for antineutrophil cytoplasmic antibody-associated systemic vasculitis: A systematic review and meta-analysis
29 Mandate in the Desert: Rebuild
30 China's First National Standard for Express Delivery Service by Unmanned Aircraft Jointly Formulated by EHang will be Effective from January 1, 2021
31 Devils re-sign Blackwood to 3-year deal with $2.8M AAV
32 Advantage Oil & Gas Ltd.'s (TSE:AAV) Intrinsic Value Is Potentially 25% Below Its Share Price
33 Storm Advisory 1/20/21: NHL News, Daily Links and Roundup
34 Colts Key 2021 Free Agents: Who Stays or Goes this Offseason?
35 SwanBio Therapeutics Appoints Alison Lawton to Board of Directors
36 Colorado Avalanche Get Roster Flexibility & Cap Space With Ian Cole Trade
37 New gene therapy methods deliver promise
38 DJ LeMahieu will thrive for the Yankees over the length of his contract
39 AAV Capsid-Promoter Interaction Shown to Occur in Non-human Primate Brain
40 Navigating the Complexities of AAV Scale-Up and Manufacturing
41 Thai AirAsia to furlough 75% of workforce
42 Marine Corps Amphibious Combat Vehicle has some serious problems
43 The culmination of the Astros’ meticulous offseason
44 Phillies: 2021's Reunion with Realmuto Draws Closer
45 Mets Payroll And The Luxury Tax
46 Ultragenyx Announces Progress Across Broad Gene Therapy Portfolio and Positive Longer-Term Data from Multiple Phase 1/2 Gene Therapy Studies
47 Redefining AAV Manufacturing: The Time Is Now
48 Thermo Fisher Takes Deep Dive into Cell and Gene Therapy with Viral Vector Business Buy
49 FDA Grants Rare Pediatric Disease, Orphan Drug Designation to Taysha's Rare Epilepsy Candidate
50 The Yankees and DJ LeMahieu knew they needed to meet in the middle
51 ChemoCentryx: Great Drug, Good Prospects, Uncomfortable Stock Price
52 A CDMO's Perspective on AAV Vector Production
53 Phillies offer J.T. 5 years, 9 figures (report)
54 Advances in AAV Vectors and Gene Therapy
55 Gene Therapy: It's Time to Talk about High-Dose AAV
56 Latest On Trevor Bauer
57 Thwarting AAV-Neutralizing Antibodies Could Improve Gene Therapy
58 Opening the Flood Gates? George Springer Signs a Big Deal with the Blue Jays
59 Scalable Plasmid-Free AAV Manufacturing
60 Global Assault Amphibious Vehicles (AAV) Sales Market Recent Trends, In-depth Analysis, Market Size Research Report Forecast up to 2025: BAE Systems, Lockheed Martin, Mitsubishi Heavy Industries, General Dynamics, Northrop Grumman
61 Mets blockbuster prompts new questions
62 Lexeo raises $85M series A to pursue new gene therapies for monogenic diseases
63 Canadiens Overpaid for Josh Anderson
64 Passage Bio to Host First of a Series of 2021 Virtual R&D Events on January 25
65 Shape Therapeutics unveils advanced AAV capsid discovery platform
66 Paralyzed Mice Walk Again after Treatment with Designer Cytokine
67 Should You Buy EHang Holdings Ltd
68 AAV-Based Gene Therapy Boosted by Curbed Immune Response
69 Major Expansions Planned for Cobra Biologics and Cognate BioServices
70 Should the New York Rangers acquire Pierre-Luc Dubois?
71 ViGeneron announces research collaboration with Daiichi Sankyo to evaluate vgAAV for novel ophthalmic gene therapy
72 Risk of AAV mobilization in gene therapy
73 IPF Risk Genes Linked to AAV in Study, But Not to AAV-associated...
74 Oxgene Introduces Technology For AAV Manufacture At Scale
75 It’s time for the Phillies to bring back Didi Gregorius
76 AAV Purification: Discussing Current Challenges
77 Roche deal latest in AAV gene therapy partnership plan for Dyno
78 Hypothyroidism More Likely in AAV Patients with Certain Autoantibodies, Study Finds
79 Tessera Therapeutics scores $230M to ramp up 'gene writing' tech to cure disease
80 Who are the highest-paid running backs in the NFL in 2021?
81 Monitoring Autoantibodies in AAV May Help Predict Remission, Relapses
82 OXGENE launches a scalable, plasmid-free manufacturing system for AAV
83 NIH gene therapy startup to increase AAV gene therapy efficiency
84 How to Solve the Production Challenges of AAVs for Gene Therapy?
85 The Escalator: AskBio appoints president of therapeutics
86 New methods could improve AAV quality for viral vector manufacturing
87 Researchers explore naturally occurring viral vectors: 'Our study will change the trajectory of AAV-based gene therapies'
88 Oral Therapy Avacopan for AAV Now Under Regulatory Review in Europe
89 Passage Bio Announces Publication of Preclinical Data That Show Single Injection of Optimized AAV Vector into Cerebral Spinal Fluid Corrects Neurological Disease, Supporting Advancement of PBGM01 into Clinic
90 New Gene Therapy Approach Prevents Toxicity Tied to AAV Vectors
91 High Relapse Risk in AAV With Recurrent, Persistent ANCA Antibodies
92 Dyno Therapeutics Enters Collaboration and License Agreement With Roche to Develop Next-Generation AAV Gene Therapy Vectors for CNS Diseases and Liver-Directed Therapies
93 AGTC Boosts AAV Manufacturing Productivity with Herpes Simplex Virus
94 AAV Carries High Healthcare Costs, Italian Study Finds
95 20S-proteasome May Be Useful Biomarker of AAV Disease Activity
96 Survey Seeks to Better Understand How AAV Patients Make Treatment...
97 AAV Gene Therapy Pioneer Jude Samulski Develops Proprietary Regulated Gene Editing System
98 Toxicity of dorsal root ganglia is widely associated with CNS AAV gene therapy
99 NIH project aims to maximize efficiency of AAV platform for gene therapy
100 Defusing antibody neutralisers in AAV gene therapy